Cargando…

The effects of antihypertensive medications on severity and outcomes of COVID19

Detalles Bibliográficos
Autor principal:	Agirbasli, Mehmet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281571/ https://www.ncbi.nlm.nih.gov/pubmed/35810205 http://dx.doi.org/10.1038/s41371-022-00722-9

Ejemplares similares

Adherence to antihypertensive medication in renal denervation trials: new studies, old problems?
por: Lauder, Lucas, et al.
Publicado: (2023)

The effects of antihypertensive medications on severity and outcomes of hypertensive patients with COVID-19
por: Nakhaie, Samira, et al.
Publicado: (2022)

Who, what, and when—effective therapy for severe COVID-19
por: Kelmenson, Daniel A, et al.
Publicado: (2022)

Azithromycin for severe COVID-19
por: Oldenburg, Catherine E, et al.
Publicado: (2020)

Increased risk of severe COVID-19 outcomes in patients with rheumatoid arthritis and interstitial lung disease
por: Kelly, Clive
Publicado: (2022)

Comments: Absolute cardiovascular risk assessment for guiding antihypertensive prescribing in Australian primary care patients with hypertension
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2022)

Thrombosis and fibrosis: mutually inclusive targets to combat in COVID-19
por: Agirbasli, Mehmet
Publicado: (2021)

COVID-19 vaccination is effective at preventing severe illness and complications during pregnancy
por: Ellington, Sascha, et al.
Publicado: (2023)

Observational research on severe COVID-19 in diabetes
por: Stehouwer, Coen D A
Publicado: (2021)

Sulfasalazine: a risk factor for severe COVID-19?
por: Konig, Maximilian F, et al.
Publicado: (2022)

Clinical course and mortality risk of severe COVID-19
por: Weiss, Paul, et al.
Publicado: (2020)

Epidemiology of severe COVID-19 from South Africa
por: Madhi, Shabir A, et al.
Publicado: (2021)

Are women with asthma at increased risk for severe COVID-19?
por: Fernando, Mario, et al.
Publicado: (2021)

Severe COVID-19 pneumonitis and timing of birth in women
por: Calvert, Clara, et al.
Publicado: (2023)

Use of aerosolised medications at home for COVID-19
por: Ari, Arzu
Publicado: (2020)

COVID-19 outcomes and the human genome
por: Murray, Michael F., et al.
Publicado: (2020)

OUTCOMES OF PATIENTS WITH COVID-19 ON ANTIHYPERTENSIVE MEDICATIONS IN SOUTHERN PENNSYLVANIA
por: CHAN, VERNON, et al.
Publicado: (2021)

Elucidating the effect of geriatric parameters on COVID-19 outcomes for older adults with cancer
por: Milton, Martine, et al.
Publicado: (2022)

Testing the efficacy of tocilizumab in patients with COVID-19 pneumonia
por: Agirbasli, Mehmet, et al.
Publicado: (2021)

Severe COVID-19 and preexisting hypertension: a matter of age?
por: Yamazaki, Osamu, et al.
Publicado: (2022)

Severe mental illness and European COVID-19 vaccination strategies
por: De Picker, Livia J, et al.
Publicado: (2021)

Mounting evidence of impaired viral control in severe COVID-19
por: Bermejo-Martin, Jesus F, et al.
Publicado: (2021)

COVID-19 severity and obesity: are MAIT cells a factor?
por: McCarthy, Cormac, et al.
Publicado: (2021)

Medical and gastroenterological education during the COVID-19 outbreak
por: Barberio, Brigida, et al.
Publicado: (2020)

The changing face of medical professionalism and the impact of COVID-19
por: Goddard, Andrew F, et al.
Publicado: (2021)

Baricitinib for patients with severe COVID-19—time to change the standard of care?
por: Supady, Alexander, et al.
Publicado: (2022)

Stimulating severe COVID-19: the potential role of GM-CSF antagonism
por: Leavis, Helen L, et al.
Publicado: (2022)

Severe COVID-19 in the young and healthy: monogenic inborn errors of immunity?
por: Zhang, Shen-Ying, et al.
Publicado: (2020)

Treatment for severe acute respiratory distress syndrome from COVID-19
por: Matthay, Michael A, et al.
Publicado: (2020)

Will helminth co-infection modulate COVID-19 severity in endemic regions?
por: Bradbury, Richard S., et al.
Publicado: (2020)

Severe breakthrough COVID-19 infections in Scotland—implications for immunisation programmes
por: Leshem, Eyal, et al.
Publicado: (2021)

A role for interleukin-1 receptor antagonism in severe COVID-19?
por: Tattersall, Rachel S, et al.
Publicado: (2021)

Retraction—Chinese medical staff request international medical assistance in fighting against COVID-19
por: The Editors of The Lancet Global Health
Publicado: (2020)

Retraction—Chinese medical personnel after the COVID-19 pandemic
por: The Editors of The Lancet
Publicado: (2023)

A longer look at COVID-19 and neuropsychiatric outcomes
por: Rogers, Jonathan P, et al.
Publicado: (2021)

Rethinking cancer clinical trials for COVID-19 and beyond
por: Doherty, Gary J., et al.
Publicado: (2020)

Managing secondary fungal infections in severe COVID-19: how to move forward?
por: Verweij, Paul E, et al.
Publicado: (2022)

Rise in diabetic ketoacidosis during the COVID-19 pandemic: several questions remain
por: Misra, Shivani
Publicado: (2022)

New insights into the association between body-mass index and severe COVID-19
por: Bhaskaran, Krishnan
Publicado: (2021)

Canadian medical student climate advocacy during the COVID-19 pandemic
por: Jane, Alanna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t87mptki6fnjpo8p6r80n12fje